428 related articles for article (PubMed ID: 10195231)
1. Prevalence of specific IgA and IgM anti-HBc antibodies compared with HBV DNA in the sera of HBsAg chronic carriers.
Elsana S; Shemer-Avni Y; Sikuler E; Sarov B; Naggan L; Bar-Shany S; Gilon E; Yaari A; Orgel M; Frazer GM; Margalith M
J Hum Virol; 1997; 1(1):52-7. PubMed ID: 10195231
[TBL] [Abstract][Full Text] [Related]
2. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
3. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
[TBL] [Abstract][Full Text] [Related]
4. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?
Galli C; Orlandini E; Penzo L; Badiale R; Caltran G; Valverde S; Gessoni G
J Med Virol; 2008 Jun; 80(6):974-9. PubMed ID: 18428144
[TBL] [Abstract][Full Text] [Related]
5. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
6. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
[TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
8. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
9. Study of relativity between HBV M and HBV DNA in the cases with hepatitis B.
Meng Q; Liang R; Liu D
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):352-4. PubMed ID: 11471024
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J
Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
12. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
Zerbini A; Pilli M; Boni C; Fisicaro P; Penna A; Di Vincenzo P; Giuberti T; Orlandini A; Raffa G; Pollicino T; Raimondo G; Ferrari C; Missale G
Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
[TBL] [Abstract][Full Text] [Related]
13. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
[TBL] [Abstract][Full Text] [Related]
14. Serological pattern of hepatitis B virus markers (HBsAg, anti-HBs, IgM anti-HBc and HBV specific DNA polymerase) in leprosy patients.
Moudgil KD; Irshad M; Gandhi BM; Mishra R
Indian J Lepr; 1989 Jan; 61(1):54-60. PubMed ID: 2649622
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of quantitative anti-HBc IgM assay in acute and chronic HBV infection.
Hadziyannis SJ; Hadziyannis AS; Dourakis S; Alexopoulou A; Horsch A; Hess G
Hepatogastroenterology; 1993 Dec; 40(6):588-92. PubMed ID: 8119645
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
17. [Virological, serological and clinical characteristics of anti-HBc IgM positive chronic hepatitis B patients].
Zhang CZ; Tian ZX; Shi SZ; Li MH; Xie Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):138-40. PubMed ID: 17653316
[TBL] [Abstract][Full Text] [Related]
18. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
Launay O; Masurel J; Servant-Delmas A; Basse-Guérineau AL; Méritet JF; Laperche S; Sogni P; Rosenberg AR
J Viral Hepat; 2011 Oct; 18(10):721-9. PubMed ID: 21914087
[TBL] [Abstract][Full Text] [Related]
19. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
20. Significance of various classes of anti-HBc in individuals with chronic asymptomatic HBV infection.
Luo KX; Lu QS
Am J Gastroenterol; 1989 Feb; 84(2):160-3. PubMed ID: 2916527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
